专利检索 ap:("JAPAN AS REPRESENTED BY DIRECTOR-GENERAL OF NATIONAL INSTITUTE OF INFECTIOUS DISEASES" OR "SAWAI PHARMACEUTICAL Co., Ltd.") AND inv:"Toru TERASHIMA" 第 1 页

1.

发明公开
STEPHANIA CEPHARANTHA-DERIVED ALKALOID-CONTAINING PREPARATION 审中-公开

公开(公告)号：US20240299481A1

公开(公告)日：2024-09-12

申请号：US18662946

申请日：2024-05-13

申请人： JAPAN AS REPRESENTED BY DIRECTOR-GENERAL OF NATIONAL INSTITUTE OF INFECTIOUS DISEASES , SAWAI PHARMACEUTICAL Co., Ltd.

发明人： Koichi WATASHI , Wakana SASO , Toru TERASHIMA

IPC分类号： A61K36/71 , A61K31/4375 , A61P31/14

CPC分类号： A61K36/71 , A61K31/4375 , A61P31/14

摘要： In an embodiment, a Stephania cepharantha-derived alkaloid-containing preparation for treatment of a novel coronavirus infection is provided. According to an embodiment of the present invention, a preparation for treatment of a novel coronavirus infection comprises Cepharanthine, Isotetrandrine, Cycleanine, and Berbamine. A preparation for treatment of a novel coronavirus infection is for treatment of an infection caused by the novel coronavirus mutant strain. According to an embodiment of the present invention, a Stephania cepharantha-derived alkaloid-containing preparation for treatment of a novel coronavirus infection is provided.